Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response to a Delayed Second Dose of Oral Cholera Vaccine

NCT05453253 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT05453253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response to a Delayed Second Dose of Oral Cholera Vaccine
Lead sponsor
Epicentre
Phase
Phase 4
Overall status
Unknown status
Start date
July 20, 2022
Completion date
July 1, 2024
Enrollment
456 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholera, vibrio cholerae infection